Sovran Advisors, LLC Novo Nordisk A S Transaction History
Sovran Advisors, LLC
- $954 Billion
- Q2 2025
A detailed history of Sovran Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sovran Advisors, LLC holds 40,930 shares of NVO stock, worth $2.82 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
40,930
Previous 36,559
11.96%
Holding current value
$2.82 Million
Previous $2.12 Billion
34.24%
% of portfolio
0.3%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,759Shares Held
339MCall Options Held
11.4MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.02 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$855 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$850 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$819 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...